Given that eIF4E and its phosphorylation are associated with processes linked to tumor progression and metastasis in a broad range of tumor types, and that MNKs are not essential [13], pharmacological inhibitors directed against MNK appear to provide an effective anti-tumor strategy non-detrimental for non-tumor cells. This evidence concerns the gene EIF4E and neoplasm.